Tuesday biggest Wall Street calls like Nvidia
CNBC • • entertainment
Key Points:
- UBS upgraded Vipshop to buy from neutral, citing earnings resilience despite near-term growth pressure due to muted consumption and e-commerce competition.
- JPMorgan initiated coverage of Seaport Therapeutics as overweight with a December 2027 price target of $42, expressing bullish sentiment on the biotech company.
- Citi initiated Pershing Square with a buy/high risk rating and a $50 price target, highlighting its strong attributes as an asset manager.
- Multiple firms upgraded technology and biotech stocks: JPMorgan raised Cognex, Timken, and Allient to overweight; Goldman Sachs initiated Hemab Therapeutics as buy; UBS reiterated Micron as buy with a significant price target increase.
- Bank of America and other analysts raised price targets on major tech companies Apple, Nvidia, and Dell, citing growth opportunities in AI, data centers, and structural industry changes.